Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management considerations in Hürthle cell carcinoma

A Azadian1, I B Rosen, P G Walfish

  • 1Department of Surgery, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

Surgery
|October 1, 1995
PubMed
Summary

Hürthle cell tumors present diagnostic challenges. This study found 18% cancer mortality, with larger tumors and capsular invasion indicating adverse outcomes for these thyroid neoplasms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature.

Endocrine-related cancer·2024
Same author

Management of Neuroendocrine Breast Carcinoma (NEBC): Review of Literature.

Oncology reviews·2024
Same author

Correction: CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.

Oncogene·2023
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, London, Ont., Sept. 19 to 22, 2002.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

Current oncology (Toronto, Ont.)·2019
Same author

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Endocrine-related cancer·2017

Area of Science:

  • Endocrinology
  • Surgical Pathology
  • Oncology

Background:

  • Hürthle cell tumors of the thyroid present diagnostic and management difficulties.
  • Accurate diagnosis and treatment are crucial for patient outcomes.

Purpose of the Study:

  • To review the clinical features and outcomes of patients diagnosed with Hürthle cell tumors post-thyroidectomy.
  • To identify factors associated with adverse outcomes in Hürthle cell tumors.

Main Methods:

  • Retrospective review of 47 patients undergoing thyroidectomy for presumptive Hürthle cell tumors (1984-1993).
  • Surgical pathologic findings were analyzed.
  • Clinical features and outcomes were reviewed for the neoplastic group.

Main Results:

Related Experiment Videos

  • Of 16 tumors, 11 (69%) were malignant. The cancer mortality rate was 18%.
  • Adverse outcome factors included tumor size >4 cm, female sex with age >60, and complete capsular invasion.
  • Nonneoplastic Hürthle cell nodules were found in 31 patients.

Conclusions:

  • Fine-needle aspiration biopsy of Hürthle cell lesions warrants surgical intervention, excluding Hashimoto's thyroiditis.
  • Total thyroidectomy, jugular node sampling, and adjuvant radioiodine are recommended for Hürthle cell neoplasms and cancer.
  • Stringent histologic interpretation is vital for understanding Hürthle cell tumor behavior and incidence.